The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial.

Collier, TJ; Pocock, SJ; McMurray, JJ; Zannad, F; Krum, H; van Veldhuisen, DJ; Swedberg, K; Shi, H; Vincent, J; Pitt, B; (2013) The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial. European heart journal, 34 (36). pp. 2823-9. ISSN 0195-668X DOI: https://doi.org/10.1093/eurheartj/eht247

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/eurheartj/eht247

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar